These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28342782)

  • 1. The modified Glasgow prognostic score in patients undergoing surgery for bone and soft tissue sarcoma.
    Morhij R; Mahendra A; Jane M; McMillan DC
    J Plast Reconstr Aesthet Surg; 2017 May; 70(5):618-624. PubMed ID: 28342782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the modified Glasgow Prognostic Score aid in the management of patients undergoing surgery for a soft-tissue sarcoma? : an international multicentre study.
    Spence S; Doonan J; Farhan-Alanie OM; Chan CD; Tong D; Cho HS; Sahu MA; Traub F; Gupta S;
    Bone Joint J; 2022 Jan; 104-B(1):168-176. PubMed ID: 34969280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
    Li Y; Liu X; Zhang J; Yao W
    Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-up.
    Toulmonde M; Le Cesne A; Mendiboure J; Blay JY; Piperno-Neumann S; Chevreau C; Delcambre C; Penel N; Terrier P; Ranchère-Vince D; Lae M; Le Guellec S; Michels JJ; Robin YM; Bellera C; Italiano A
    Cancer; 2014 Oct; 120(19):3003-6. PubMed ID: 24942887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma.
    Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A
    Bone Joint J; 2015 Jun; 97-B(6):847-52. PubMed ID: 26033068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
    Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
    Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inflammatory response predicts oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient colorectal cancer.
    Climent M; Ryan ÉJ; Stakelum Á; Khaw YL; Creavin B; Lloyd A; Alhassan D; Mohan HM; Kennelly R; Sheahan K; Winter DC
    Int J Colorectal Dis; 2019 Jun; 34(6):1069-1078. PubMed ID: 30993458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma.
    Farhan-Alanie OM; McMahon J; McMillan DC
    Br J Oral Maxillofac Surg; 2015 Feb; 53(2):126-31. PubMed ID: 25440150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes.
    Potter BK; Hwang PF; Forsberg JA; Hampton CB; Graybill JC; Peoples GE; Stojadinovic A
    J Bone Joint Surg Am; 2013 Oct; 95(20):e151. PubMed ID: 24132366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is a useful marker for predicting survival in patients with high-grade soft tissue sarcoma who have non-inflammatory conditions?
    Nakamura T; Asanuma K; Hagi T; Sudo A
    J Orthop Sci; 2024 Jul; 29(4):1125-1129. PubMed ID: 37537113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic index for extremity soft tissue sarcomas with isolated local recurrence.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 2001 May; 8(4):278-89. PubMed ID: 11352300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade soft tissue sarcomas of the extremities: surgical margins influence only local recurrence not overall survival.
    Willeumier J; Fiocco M; Nout R; Dijkstra S; Aston W; Pollock R; Hartgrink H; Bovée J; van de Sande M
    Int Orthop; 2015 May; 39(5):935-41. PubMed ID: 25743028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
    Choi ES; Kim HS; Han I
    Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
    Alektiar KM; Brennan MF; Singer S
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The width of resection margins influences local recurrence in soft tissue sarcoma patients.
    Kainhofer V; Smolle MA; Szkandera J; Liegl-Atzwanger B; Maurer-Ertl W; Gerger A; Riedl J; Leithner A
    Eur J Surg Oncol; 2016 Jun; 42(6):899-906. PubMed ID: 27107792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of the preoperative systemic immune-inflammation index and high-sensitivity modified Glasgow prognostic score in patients after radical operation for soft tissue sarcoma.
    Hou T; Guo T; Nie R; Hong D; Zhou Z; Zhang X; Liang Y
    Eur J Surg Oncol; 2020 Aug; 46(8):1496-1502. PubMed ID: 32576479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft-tissue sarcomas of the chest wall: prognostic factors.
    Gross JL; Younes RN; Haddad FJ; Deheinzelin D; Pinto CA; Costa ML
    Chest; 2005 Mar; 127(3):902-8. PubMed ID: 15764774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.